ANSYS - FDA - Avicenna
Roundtable Discussion

SAVE THE DATE! Roundtable discussion in Washington on 11 October 2019

 

For those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?". 

 

The goal of the meeting is to discuss opportunities and challenges when utilizing in silico approaches during development and regulatory review.  The event will be organized around 2 panel discussions, where senior leaders from the largest medical device and pharmaceutical companies will be sharing their experience and expectations.

When and where: 11 October 2019, Marriott at Hyattsville Maryland (same hotel as BMES Conference).

 

Please register here to reserve your spot.

Do not hesitate to contact Krista Loeffler at krista.loeffler@ansys.com for more information.

 

The draft agenda is structured as follows:

Avicenna Alliance news

The Avicenna Alliance co-organises a public workshop at the FDA on good simulation practices in health technologies

The Avicenna Alliance, the Medical Device Innovation Consortium (MDIC) and the...

find out more ›

The Avicenna Alliance nominated as a member of the European Commission's "eHealth Stakeholder Group"

On 3 February, Thierry Marchal, Secretary-General of the Avicenna Alliance has been informed that...

find out more ›

Avicenna Alliance puts forward questions to EU Expert Panel on effective ways of investing in health

On 17 December the European Commission launched a survey inviting stakeholders to put forward...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up